These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 5111969

  • 1. Blocking considerations in mantle therapy.
    Maruyama Y, Khan FM.
    Radiology; 1971 Oct; 101(1):167-73. PubMed ID: 5111969
    [No Abstract] [Full Text] [Related]

  • 2. [The appearance of radiation-induced lesions after radiotherapy for Hodgkin's disease of the mediastinum and lungs (author's transl)].
    Zomer-drozda J.
    Pol Przegl Radiol Med Nukl; 1976 Oct; 40(4):247-50. PubMed ID: 980933
    [No Abstract] [Full Text] [Related]

  • 3. Prevention of radiation injury: predictability and preventability of complications of radiation therapy.
    Stewart JR, Gibbs FA.
    Annu Rev Med; 1982 Oct; 33():385-95. PubMed ID: 7081967
    [No Abstract] [Full Text] [Related]

  • 4. Results of lung irradiation for Hodgkin's disease patient with large mediastinal masses and/or hilar disease.
    Lee CK, Bloomfield CD, Levitt SH.
    Cancer Treat Rep; 1982 Apr; 66(4):819-25. PubMed ID: 7074653
    [Abstract] [Full Text] [Related]

  • 5. [Clinical aspects of use of inhibition radiation from an electron accelerator].
    Rabukhina NA, Barkanov AI, Grech IG, Porokhova NP.
    Med Radiol (Mosk); 1972 Sep; 17(9):83-94. PubMed ID: 4581845
    [No Abstract] [Full Text] [Related]

  • 6. Daily reproducibility of lung blocks in the mantle technique.
    McCord DL, Million RR, Northrop MF, Kavanaugh HV.
    Radiology; 1973 Dec; 109(3):735-6. PubMed ID: 4772198
    [No Abstract] [Full Text] [Related]

  • 7. [Reticulum cell sarcoma of head and neck treated by radiotherapy].
    Ikeda H, Masaki N.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1971 Aug 25; 31(5):515-27. PubMed ID: 4946426
    [No Abstract] [Full Text] [Related]

  • 8. The use of thin lung shields to deliver limited whole-lung irradiation during mantle-field treatment of Hodgkin's disease.
    Palos B, Kaplan HS, Karzmark CJ.
    Radiology; 1971 Nov 25; 101(2):441-2. PubMed ID: 5114786
    [No Abstract] [Full Text] [Related]

  • 9. [Pulmonary and mediastinal tumor (author's transl)].
    Imajo Y, Ogawa Y, Takashima H, Okuno T, Matsuura S, Ishida T, Kohno M.
    Rinsho Hoshasen; 1981 Aug 26; 26(8):841-6. PubMed ID: 7289146
    [No Abstract] [Full Text] [Related]

  • 10. The therapeutic utility of lung irradiation for Hodgkin's disease patients with large mediastinal masses.
    Lee CK, Bloomfield CD, Goldman AI, Nesbit ME, Levitt SH.
    Int J Radiat Oncol Biol Phys; 1981 Feb 26; 7(2):151-4. PubMed ID: 7216852
    [No Abstract] [Full Text] [Related]

  • 11. [Lymphosarcomas and reticulosarcomas of the upper aerodigestive tract. Natural history and results of radiotherapy].
    Brugère J, Schleinger M, Gérard-Marchant R, Tubiana M, Pouillart P, Cachin Y.
    Bull Cancer; 1974 Feb 26; 61(1):79-92. PubMed ID: 4617613
    [No Abstract] [Full Text] [Related]

  • 12. [Radiation myelopathy].
    Fröscher W, Müller J, Vahar-Matiar H.
    Nervenarzt; 1975 Jul 26; 46(7):391-6. PubMed ID: 1207857
    [No Abstract] [Full Text] [Related]

  • 13. Stage II Hodgkin's disease. Significance of mediastinal and nonmediastinal presentations.
    Fuller LM, Gamble JF, Ibrahim E, Jing BS, Butler JJ, Shullenberger CC.
    Radiology; 1973 Nov 26; 109(2):429-32. PubMed ID: 4742328
    [No Abstract] [Full Text] [Related]

  • 14. [Apropos of radiotherapeutic results in the treatment of lymphoreticulosarcomas with the exception of generalized forms].
    Ennuyer A, Bataini P.
    Schweiz Med Wochenschr; 1967 Nov 04; 97(44):1455-9. PubMed ID: 4874644
    [No Abstract] [Full Text] [Related]

  • 15. [Clinico-statistical considerations on 104 cases of lymphosarcoma].
    Carnevali G, Salvini E.
    Radiol Med; 1967 Dec 04; 53(12):1278-92. PubMed ID: 5192131
    [No Abstract] [Full Text] [Related]

  • 16. Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: dose constraints to virtual volumes or to organs at risk?
    Ghalibafian M, Beaudre A, Girinsky T.
    Radiother Oncol; 2008 Apr 04; 87(1):82-8. PubMed ID: 18037182
    [Abstract] [Full Text] [Related]

  • 17. [Causes and differences of recurrences in lymphogranulomatosis following primary radiation therapy (author's transl)].
    Sack H, Röttinger EM, Rixen G.
    Strahlentherapie; 1978 Oct 04; 154(10):663-7. PubMed ID: 694956
    [Abstract] [Full Text] [Related]

  • 18. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
    Hoppe BS, Flampouri S, Su Z, Morris CG, Latif N, Dang NH, Lynch J, Li Z, Mendenhall NP.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):260-7. PubMed ID: 22014950
    [Abstract] [Full Text] [Related]

  • 19. [Diseases of the thoracic organs in lymphogranulomatosis].
    Novikova EZ, Savel'eva GS, Khokhlova MP.
    Probl Gematol Pereliv Krovi; 1971 Mar 01; 16(3):27-34. PubMed ID: 5119053
    [No Abstract] [Full Text] [Related]

  • 20. [Principles of radiotherapy in tumors of the cervico-mediastinal junction].
    Bertoni F, Bignardi M.
    Acta Otorhinolaryngol Ital; 1990 Mar 01; 10 Suppl 30():129-38. PubMed ID: 2103668
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.